ClinicalTrials.gov
ClinicalTrials.gov Menu

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy (HCMR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01915615
Recruitment Status : Active, not recruiting
First Posted : August 5, 2013
Last Update Posted : May 1, 2018
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
Oxford University Hospitals NHS Trust
Information provided by (Responsible Party):
Christopher M. Kramer MD, University of Virginia